Moreover, activated CD4+ T cells in severe COVID-19 patients expressed higher levels of CD25, while suppressing the expression of FoxP3, resulting in a disrupted FoxP3-mediated mechanism in the lung [63]. This evidence concerns the gene FOXP3 and COVID-19.